EHI
BEAM icon

Eagle Health Investments’s Beam Therapeutics BEAM Stock Holding History

Eagle Health Investments’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-28,900
Closed -$885K – 29
2023
Q1 		$885K Hold
28,900
– – 0.17% 25
2022
Q4 		$1.13M Hold
28,900
– – 0.26% 22
2022
Q3 		$1.38M Hold
28,900
– – 0.32% 24
2022
Q2 		$1.12M Hold
28,900
– – 0.26% 24
2022
Q1 		$1.66M Hold
28,900
– – 0.41% 23
2021
Q4 		$2.3M Buy
+28,900
New +$2.47M 0.56% 24

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eagle Health Investments's BEAM Position: Q2 2023 in Review

Eagle Health Investments sold out of Beam Therapeutics (BEAM) in Q2 2023, closing a stake of 28,900 shares — an estimated $885K sold.

Eagle Health Investments first reported a position in BEAM in Q4 2021 and held it in 6 quarters. The position peaked at $2.3M in Q4 2021. 194 funds tracked by Wall St. Rank hold BEAM as of Q2 2023.

  • Eagle Health Investments reported no remaining Beam Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Eagle Health Investments sold 28,900 Beam Therapeutics shares in Q2 2023, an estimated $885K.
  • Eagle Health Investments first reported a position in Beam Therapeutics in Q4 2021 and held it in 6 quarters.
  • Eagle Health Investments's Beam Therapeutics position peaked at $2.3M in Q4 2021.
  • 194 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2023.

Based on Eagle Health Investments's 13F filing for Q2 2023, filed 14 Aug 2023.